Site Menu

Home

NIH Human Embryonic Stem Cell Registry
Research Using This Line is Eligible for NIH Funding

Detailed information for selected cell line:

Cell Line: CSES22; abnormal karyotype
NIH Registration Number: 0119
NIH Approval Number: NIHhESC-11-0119
Available for Distribution: Other - Unknown at this time
Provider Restrictions: HESC recipients must provide documentation of ESCRO, IRB or equivalent ethical review for the research planned with the requested cell lines.

NIH Restrictions: (No Additional Restrictions)
Additional Information: The karyotype for this cell line is 47,XX,+16 (15), 47,XX,+15 (2), 46,XX, t(16;22) (1), 47,XX,+5, t(16;22) (1), 46,XX (1).

Submitting Organization: Cedars-Sinai Medical Center
Provider Name: Dhruv Sareen, Ph.D.
Provider Phone: (310) 423-7074
Provider Email: ipsccore@cshs.org
Provider URL: http://cedars-sinai.edu/Research/Research-Cores/Induced-Pluripotent-Stem-Cell-Core-/index.aspx
Approval Date: 06/10/2011


View All Lines Eligible for Use

Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page


   
Related Resources

    NIH Form 2890:

  • Login Page
    (Authorization Required)
    Contact Us:

  • Email questions to:
    hescregistry@mail.nih.gov

    • (Emails that are offensive or unrelated to stem cells will be deleted.)
 

This page last updated on July 13, 2011 
Content Manager: stemcell@mail.nih.gov 
Technical Issues: E-mail OER Webmaster